AFCR News

A Breakthrough Approach to “Undruggable” Targets THE CHALLENGE: Undruggable Targets In Cancer Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…

Position Overview: The Director of Marketing and Business Development at the Asian Fund for Cancer Research (AFCR) is responsible for driving the foundation’s growth in Hong Kong and the Asia-Pacific region by developing and executing comprehensive marketing strategies, managing strategic partnerships, and…

NOTABLE RESEARCH HIGHLIGHTS AFCR-supported scientists have made remarkable advances in the fight against cancer. Here are some notable research highlights in 2024 supported by your generous donations. First-in Class Molecular Glue Degraders Dr. Lily Zou’s research is at the forefront of developing a novel…

The 2024 Give to Cure Cancer Year-End Appeal is now underway. This is a chance to make this year’s campaign the most successful ever. We are proud to report... With support from loyal donors, excellent progress has been made in these AFCR-funded projects in…

The 2024 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted by the National Foundation for Cancer Research (NFCR), AIM-HI Accelerator Fund (AIM-HI), and Asian Fund for Cancer Research (AFCR) will be held on October 18th at the National…

AFCR will celebrate its 20 Year Anniversary in 2025. In those 20 years, AFCR has been focused on funding cancer research, especially those cancers prevalent in Asian populations. Here is a snapshot of the research fields we will fund during 2024-2025. CHANGING THE…